Health Sciences Acquisitions Corporation 2
HSAQ · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $490,088,069 | $163,930 | $204,361 | $259,709 |
| - Cash | $22,261 | $175 | $1,754 | $2,027 |
| + Debt | $2,237 | $0 | $0 | $0 |
| Enterprise Value | $490,068,045 | $163,755 | $202,607 | $257,682 |
| Revenue | $2,638 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $2,434 | $0 | $0 | $0 |
| % Margin | 92.3% | – | – | – |
| EBITDA | -$64,301 | -$2,735 | -$379 | -$174 |
| % Margin | -2,437.5% | – | – | – |
| Net Income | -$61,024 | -$2,390 | -$363 | -$174 |
| % Margin | -2,313.3% | – | – | – |
| EPS Diluted | -1.66 | -0.15 | -0.018 | -0.009 |
| % Growth | -1,006.7% | -738% | -108.1% | – |
| Operating Cash Flow | -$50,558 | -$1,579 | -$272 | -$259 |
| Capital Expenditures | -$289 | $0 | $0 | $0 |
| Free Cash Flow | -$50,847 | -$1,579 | -$272 | -$259 |